Independent Solutions Wealth Management, LLC Bristol Myers Squibb CO Transaction History

Independent Solutions Wealth Management, LLC

$442 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Dec 19, 2024	SELL	$48.48 - $57.85 $460,075 - $548,996	-9,490 Reduced 65.86%	4,920 $252 Million
Q3 2023 Dec 19, 2024	BUY	$57.89 - $64.73 $834,194 - $932,759	14,410 New	14,410 $836 Million
Q2 2023 Dec 19, 2024	SELL	$63.71 - $70.74 $315,045 - $349,809	-4,945 Closed	0 $0
Q1 2023 Dec 19, 2024	BUY	$65.71 - $74.53 $60,913 - $69,089	927 Added 23.07%	4,945 $343 Million
Q4 2022 Dec 19, 2024	BUY	$68.48 - $81.09 $3,150 - $3,730	46 Added 1.16%	4,018 $289 Million
Q3 2022 Dec 19, 2024	BUY	$0.13 - $76.84 $14 - $8,682	113 Added 2.93%	3,972 $282 Million
Q2 2022 Dec 19, 2024	BUY	$72.62 - $79.98 $280,240 - $308,642	3,859 New	3,859 $297 Million
Q4 2021 Dec 19, 2024	SELL	$53.63 - $62.52 $317,972 - $370,681	-5,929 Closed	0 $0
Q3 2021 Dec 19, 2024	BUY	$59.17 - $69.31 $59,170 - $69,310	1,000 Added 20.29%	5,929 $351 Million
Q2 2021 Dec 19, 2024	BUY	$61.91 - $67.42 $305,154 - $332,313	4,929 New	4,929 $329 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$10.7 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.01 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.28 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.43 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.47 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Independent Solutions Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Independent Solutions Wealth Management, LLC with notifications on news.

Account